SciVision Biotech's market value is the price at which a share of SciVision Biotech trades on a public exchange. It measures the collective expectations of SciVision Biotech investors about its performance. SciVision Biotech is selling for under 113.00 as of the 11th of January 2025; that is 0.88 percent decrease since the beginning of the trading day. The stock's lowest day price was 109.0. With this module, you can estimate the performance of a buy and hold strategy of SciVision Biotech and determine expected loss or profit from investing in SciVision Biotech over a given investment horizon. Check out SciVision Biotech Correlation, SciVision Biotech Volatility and SciVision Biotech Alpha and Beta module to complement your research on SciVision Biotech.
Please note, there is a significant difference between SciVision Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if SciVision Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SciVision Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
SciVision Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to SciVision Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of SciVision Biotech.
0.00
06/15/2024
No Change 0.00
0.0
In 6 months and 29 days
01/11/2025
0.00
If you would invest 0.00 in SciVision Biotech on June 15, 2024 and sell it all today you would earn a total of 0.00 from holding SciVision Biotech or generate 0.0% return on investment in SciVision Biotech over 210 days. SciVision Biotech is related to or competes with Maxigen Biotech, Chunghwa Chemical, Sinphar Pharmaceutical, ScinoPharm Taiwan, and Apex Biotechnology. SciVision Biotech Inc. manufactures and sells hyaluronic acid products in Taiwan More
SciVision Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure SciVision Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess SciVision Biotech upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for SciVision Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as SciVision Biotech's standard deviation. In reality, there are many statistical measures that can use SciVision Biotech historical prices to predict the future SciVision Biotech's volatility.
At this stage we consider SciVision Stock to be very steady. SciVision Biotech owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0362, which indicates the firm had a 0.0362% return per unit of risk over the last 3 months. We have found twenty-three technical indicators for SciVision Biotech, which you can use to evaluate the volatility of the company. Please validate SciVision Biotech's Risk Adjusted Performance of (0.03), variance of 6.42, and Coefficient Of Variation of (1,928) to confirm if the risk estimate we provide is consistent with the expected return of 0.0807%. SciVision Biotech has a performance score of 2 on a scale of 0 to 100. The entity has a beta of 0.13, which indicates not very significant fluctuations relative to the market. As returns on the market increase, SciVision Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding SciVision Biotech is expected to be smaller as well. SciVision Biotech right now has a risk of 2.23%. Please validate SciVision Biotech mean deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if SciVision Biotech will be following its existing price patterns.
Auto-correlation
0.18
Very weak predictability
SciVision Biotech has very weak predictability. Overlapping area represents the amount of predictability between SciVision Biotech time series from 15th of June 2024 to 28th of September 2024 and 28th of September 2024 to 11th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of SciVision Biotech price movement. The serial correlation of 0.18 indicates that over 18.0% of current SciVision Biotech price fluctuation can be explain by its past prices.
Correlation Coefficient
0.18
Spearman Rank Test
-0.28
Residual Average
0.0
Price Variance
129.36
SciVision Biotech lagged returns against current returns
Autocorrelation, which is SciVision Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting SciVision Biotech's stock expected returns. We can calculate the autocorrelation of SciVision Biotech returns to help us make a trade decision. For example, suppose you find that SciVision Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
SciVision Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If SciVision Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if SciVision Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in SciVision Biotech stock over time.
Current vs Lagged Prices
Timeline
SciVision Biotech Lagged Returns
When evaluating SciVision Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of SciVision Biotech stock have on its future price. SciVision Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, SciVision Biotech autocorrelation shows the relationship between SciVision Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in SciVision Biotech.
Regressed Prices
Timeline
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When running SciVision Biotech's price analysis, check to measure SciVision Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SciVision Biotech is operating at the current time. Most of SciVision Biotech's value examination focuses on studying past and present price action to predict the probability of SciVision Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SciVision Biotech's price. Additionally, you may evaluate how the addition of SciVision Biotech to your portfolios can decrease your overall portfolio volatility.